XTL BIOPHARMACEUTICALS LTD. Increase Decrease Through Share-based Payment Transactions
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease Through Share-based Payment Transactions of $264.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2025-04-30
- XTL BIOPHARMACEUTICALS LTD. increase decrease through share-based payment transactions for the quarter ending 2021-06-30 was $10.00K.
- XTL BIOPHARMACEUTICALS LTD. increase decrease through share-based payment transactions for the quarter ending 2020-06-30 was -$6.00K.
| Period end | Increase Decrease Through Share-based Payment Transactions 3 month | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|---|
| 2024-12-31 | $264.00K 20-F · filed 2025-04-30 | ||
| 2023-12-31 | $3.00K 20-F · filed 2025-04-30 | ||
| 2022-12-31 | $14.00K 20-F · filed 2025-04-30 | ||
| 2022-06-30 | $9.00K 6-K · filed 2022-08-24 | ||
| 2021-12-31 | $37.00K 20-F · filed 2023-03-22 | ||
| 2021-06-30 | $10.00K 6-K · filed 2021-08-24 | $23.00K 6-K · filed 2022-08-24 | |
| 2020-12-31 | $51.00K 20-F · filed 2023-03-22 | ||
| 2020-06-30 | -$6.00K 6-K · filed 2021-08-24 | $12.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | $5.00K 20-F · filed 2022-03-30 | ||
| 2018-12-31 | $24.00K 20-F/A · filed 2021-05-19 | ||
| 2017-12-31 | $40.00K 20-F · filed 2020-03-12 | ||
| 2016-12-31 | $128.00K 20-F · filed 2019-03-11 | ||
| 2015-12-31 | $148.00K 20-F · filed 2018-03-15 |